# Magnesium: What the Evidence Says Canonical: https://www.migaku.app/guides/magnesium-evidence-review Category: evidence-review Summary: Magnesium has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclus Last reviewed: 2026-05-20 Reviewed by: Migaku Evidence Review # Magnesium: What the Evidence Says ## Quick Answer Magnesium has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice. ## Key Takeaways - This page is generated only from sources stored in the Migaku evidence knowledge base. - Current evidence mix: 1 systematic review, 1 narrative review. - Claims should be interpreted with the source type, study design, population, and publication date in mind. - This article is educational and does not replace care from a qualified clinician. ## Evidence Map | Source | Evidence type | Level | Date | Identifier | | --- | --- | ---: | --- | --- | | Association Between Levels of Magnesium and Diabetic Retinopathy in Diabetic Patients with Type 2 Diabetes Mellitus: An Updated Systematic Review and Meta-Analysis | systematic review | 1 | 2026-04-06 | 10.3390/nu18071162 | | Hypomagnesemia: A Clinical and Nutritional Update | narrative review | 3 | 2026-03-24 | 10.1007/s13668-026-00745-5 | ## What The Sources Report - Disturbance in magnesium levels has been associated with insulin resistance, endothelial dysfunction, and increased oxidative stress in the background of type 2 diabetes mellitus. [Kubbara Eman A. (2026); evidence level 1] - Therefore, reduced magnesium levels may permit excessive intracellular calcium and sodium influx, leading to excitotoxic neuronal damage that contributes to diabetic retinopathy. [Kubbara Eman A. (2026); evidence level 1] - Thus, this review aims to integrate advances in magnesium physiology with contemporary clinical and nutritional evidence, providing a consolidated strategy for understanding the causes, manifestations, diagnosis, and management of hypomagnesemia. [Papagiannidou Anastasia (2026); evidence level 3] - Finally, we also cover practical laboratory assessment and evidence-informed repletion strategies. [Papagiannidou Anastasia (2026); evidence level 3] ## How To Read This Evidence Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade. ## Practical Interpretation There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For magnesium, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence. ## Bottom Line For Readers For magnesium, this knowledge-base sample includes at least one stronger evidence source. One representative source-reported claim is: "Disturbance in magnesium levels has been associated with insulin resistance, endothelial dysfunction, and increased oxidative stress in the background of type 2 diabetes mellitus." The safest editorial posture is to separate general magnesium physiology from claims about specific outcomes, forms, or doses. ## Evidence Strength The current evidence set includes 2 unique source documents. 1 source is level 1-2 in this system, while 1 source is lower-level, indirect, narrative, or early-stage evidence. Treat this as a structured reading guide rather than a final clinical guideline. ## What This Means In Practice - Separate dietary magnesium, supplemental magnesium, and medical hypomagnesemia. - Avoid implying that every magnesium form has the same absorption, tolerance, or use case. - Flag kidney disease, medication interactions, pregnancy, and high-dose supplementation as clinician-discussion contexts. ## What The Evidence Does Not Prove - It does not prove that magnesium supplementation improves sleep, anxiety, cramps, or glucose control for every reader. - It does not prove that one supplement form is always superior without form-specific comparative evidence. ## Editorial Use Cases This page is most useful as a citation hub for answer-first pages about magnesium. It can support cautious explainers, comparison sections, safety notes, and evidence tables. It should not be used alone to rank products, promise outcomes, or replace condition-specific clinical guidance. ## Limits Of This First Pass This deep evidence page is still generated from a bounded knowledge-base sample. It should be reviewed by a human editor before being used for high-stakes decisions or product-ranking claims. ## References - Kubbara Eman A. (2026). Association Between Levels of Magnesium and Diabetic Retinopathy in Diabetic Patients with Type 2 Diabetes Mellitus: An Updated Systematic Review and Meta-Analysis. DOI: 10.3390/nu18071162. PMCID: PMC13074579. PMID: 41978212. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13074579/ - Papagiannidou Anastasia (2026). Hypomagnesemia: A Clinical and Nutritional Update. DOI: 10.1007/s13668-026-00745-5. PMCID: PMC13009017. PMID: 41872423. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13009017/ ## Safety Note Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.